Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
4
×
life sciences
national
4
×
national blog main
national top stories
biotech
merck
new york blog main
new york top stories
san francisco top stories
abbvie
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
drugs
eli lilly
genentech
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
acne
agenus
allergan
What
approved
4
×
fda
drug
new
medicine
treatment
adults
allergan
atrophy
bio
cancer
class
companies
daily
deeper
digital
disease
dna
epidemic
evrysdi
fatty
fingerprint
frenzied
friday
genetic
going
green
growing
home
intended
known
led
lights
liquid
liver
matter
medicines
merck
migraine
monday
Language
unset
Current search:
fda
×
national
×
approved
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues